PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

🧠 Clinical library

Clinical Specialty Index

456 articles indexed across 24 specialties, each reviewed by a licensed pharmacist before publication.

Showing 23 from 1 topic.Sort: Newest | Oldest
2026 Dyslipidemia Guideline Expands Statin Eligibility to Lower-Risk Adults
Analysis Cardiology Confirmatory Grade: Moderate

2026 guidelines broaden statin eligibility, reaching more younger adults.

Extended DAPT Cuts Ischemic Events in Multivessel CAD
Analysis Cardiology Practice-changing Grade: Moderate

Extended DAPT reduces ischemic events post-stent in multivessel CAD.

Most Post-Stroke Patients Miss Blood Pressure Targets in CONVINCE
Analysis Cardiology Confirmatory Grade: Moderate
Also in Neurology / Neuropharmacology

Most post-stroke patients miss new BP guidelines.

GDMT Linked to Lower Mortality in LVAD Recipients
Analysis Cardiology Hypothesis-generating Grade: Low
Also in Clinical Practice

GDMT boosts survival in LVAD patients, but why so underused?

SGLT2 Inhibitor Uptake Rises but Misses Highest-Risk HFrEF Patients
Analysis Cardiology Hypothesis-generating Grade: Low

In-hospital SGLT2 initiation slashes heart failure readmissions.

LAAC Noninferior to NOAC in Anticoagulation-Eligible AF
Analysis Anticoagulation / Hematology Hypothesis-generating Grade: Moderate
Also in Cardiology

Atrial appendage closure reduces bleeding in atrial fibrillation.

Finerenone Cuts Heart Failure Events in HFmrEF and HFpEF
★ Editor's Pick Analysis Cardiology Practice-changing Grade: High

Finerenone cuts heart failure events in HFmrEF and HFpEF.

LAAC Noninferior to DOACs in High-Risk Atrial Fibrillation
Analysis Anticoagulation / Hematology Hypothesis-generating Grade: Moderate
Also in Cardiology

LAAC proves noninferior to DOACs in high-risk AF stroke prevention.